滄州明珠(002108.SZ)業績快報:上半年淨利潤8280.67萬元 同比下降6.15%
格隆匯8月15日丨滄州明珠(002108.SZ)公佈2025年半年度業績快報,上半年公司實現營業總收入13.19億元,較上年同期增加6.88%;實現歸屬於上市公司股東的淨利潤8280.67萬元,較上年同期下降6.15%。
報告期,公司 PE管道產品銷售收入少於去年同期,主要是銷售價格較上年同期有所下降,產品銷量、毛利率均無明顯變化;BOPA薄膜產品銷量及銷售收入均高於去年同期,且盈利能力有所增加,主要是產品單位售價下降的幅度小於單位成本的下降幅度,導致毛利率同比增加;鋰離子電池隔膜產品銷量高於去年同期,但受市場影響,售價降低較多,由於成本也較同期有所下降,造成毛利率較去年同期變化不大。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.